Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
02/26/2009 | US20090054420 Bicyclic-substituted amines as histamine-3 receptor ligands |
02/26/2009 | US20090054378 Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines |
02/26/2009 | US20090054372 Combination therapy for weight loss |
02/26/2009 | US20090054356 1-substituted-7-(b-d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same |
02/26/2009 | US20090054347 Kinin b1 receptor peptide agonists and uses thereof |
02/26/2009 | US20090054336 Binding Agent |
02/26/2009 | US20090054326 Formulations for enhanced mucosal delivery of pyy |
02/26/2009 | US20090054323 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT |
02/26/2009 | US20090054315 Counteracting Drug-Induced Obesity Using GLP-1 Agonists |
02/26/2009 | US20090054314 Combined use of DPP-IV inhibitors and gastrin compounds |
02/26/2009 | US20090054305 Mixtures of Amylin and Insulin |
02/26/2009 | US20090054304 Heterocyclic modulators of tgr5 for treatment of disease |
02/26/2009 | US20090054303 Crystal forms of saxagliptin and processes for preparing same |
02/26/2009 | US20090054302 Methods and Preparations For Curing Clinically Ill Patients |
02/26/2009 | US20090053805 Post-partum mammalian placenta, its use and placental stem cells therefrom |
02/26/2009 | US20090053332 Compositions for diabetes treatment and prophylaxis |
02/26/2009 | US20090053303 Medical food or nutritional supplement, method of manufacturing same, and method of managing diabetes |
02/26/2009 | US20090053199 Stable Dairy Components Effective for Fat Loss |
02/26/2009 | US20090053197 Transfer Factor Compositions and Methods |
02/26/2009 | US20090053181 Modulation of Cells |
02/26/2009 | CA2696693A1 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof |
02/26/2009 | CA2696252A1 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
02/26/2009 | CA2695511A1 4-pyrimidinesulfamide derivative |
02/26/2009 | CA2695434A1 Chemical compounds 979 |
02/25/2009 | EP2028274A2 An antisense oligonucleotide against the TGF-beta2 gene |
02/25/2009 | EP2028269A1 Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or Exendin-4 and uses thereof |
02/25/2009 | EP2028192A1 GLP-1 and methods for treating diabetes |
02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
02/25/2009 | EP2027864A1 Composition for improvement of lipid metabolism |
02/25/2009 | EP2027863A1 Intestinal eosinophil-suppressing composition |
02/25/2009 | EP2027783A1 Functional food composition that is rich in phenolic compounds and use of said composition |
02/25/2009 | EP2027132A1 Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists |
02/25/2009 | EP2027121A1 Cyclic amine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
02/25/2009 | EP2027113A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
02/25/2009 | EP2026842A1 N-terminal modified peg-trail, method for preparing and uses thereof |
02/25/2009 | EP2026801A2 Method of treatment of hereditary hemochromatosis |
02/25/2009 | EP2026798A1 Pharmaceutical compositions comprising cbx cannabinoid receptor modulators and potassium channel modulators |
02/25/2009 | EP2026794A1 Xanthone derivative for the treatment of muscular disorders |
02/25/2009 | EP2026791A1 Maternal supplement |
02/25/2009 | EP2026787A1 Tablet formulation comprising repaglinide and metformin |
02/25/2009 | EP1907370B1 Novel 1,4-benzothiazepine-1,1-dioxide derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof |
02/25/2009 | EP1572180B1 Use of alpha-phenylthiocarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity |
02/25/2009 | EP1471920B1 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
02/25/2009 | EP1381361B1 Combination therapy comprising glucose reabsorption inhibitors and ppar modulators |
02/25/2009 | EP1254106B1 Calcilytic compounds |
02/25/2009 | EP1143965B1 Carbocyclic potassium channel inhibitors |
02/25/2009 | EP1027056B1 Alpha-ketoamide multicatalytic protease inhibitors |
02/25/2009 | CN101374842A Azepinoindole derivatives as pharmaceutical agents |
02/25/2009 | CN101374841A Spiro imidazole derivatives as PPAR modulators |
02/25/2009 | CN101374837A Novel heterocyclic oxime derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
02/25/2009 | CN101374834A Compounds and methods for modulating FXR |
02/25/2009 | CN101374833A Novel pyrone-indole derivatives and process for their preparation |
02/25/2009 | CN101374817A Trisubstituted amine compound as inhibitors of cholesteryl ester transfer protein cetp |
02/25/2009 | CN101374800A Mandelic hydrazides |
02/25/2009 | CN101374523A Dipeptidyl peptidase inhibitors for treating diabetes |
02/25/2009 | CN101374520A Remedy for diabetic |
02/25/2009 | CN101371924A Therapy of autoimmune disease in a patient with an inadequate response to a TNF-ALPHA inhibitor |
02/25/2009 | CN101371919A Mouse model with zinc finger protein ZBTB20 specific gene knockout in pancreatic gland beta cell and use |
02/25/2009 | CN101371910A Orally taken Chinese medicine composition for treating diabetes |
02/25/2009 | CN101371902A Effect of natural active glycogen for reducing blood sugar and blood fat |
02/25/2009 | CN101371894A Pollen medicine for lack of appetite |
02/25/2009 | CN101371887A Application of volatile oil of plant in preparing medicament for treating diabetes |
02/25/2009 | CN101371886A Application of volatile oil of plant belonging to citrus in preparing medicament for treating diabetes |
02/25/2009 | CN101371885A Pharmaceutical combination for preventing birth-defect and improving memory |
02/25/2009 | CN101371884A Pharmaceutical combination for preventing birth-defect and improving memory |
02/25/2009 | CN101371883A Pharmaceutical combination for preventing birth-defect and improving memory |
02/25/2009 | CN101371876A Method for extracting and preparing total polysaccharide of compound abnormal savda mature agent |
02/25/2009 | CN101371875A Method for extracting and preparing total saponin of compound abnormal savda mature agent |
02/25/2009 | CN101371874A Pharmaceutical combination for preventing birth-defect and improving memory |
02/25/2009 | CN101371873A Pharmaceutical combination for preventing birth-defect and improving memory |
02/25/2009 | CN101371867A Pharmaceutical combination for preventing birth-defect and improving memory |
02/25/2009 | CN101371866A Pharmaceutical combination for preventing birth-defect and improving memory |
02/25/2009 | CN101371865A Pharmaceutical combination for preventing birth-defect and improving memory and intelligence |
02/25/2009 | CN101371863A Pharmaceutical combination for preventing birth-defect and improving memory |
02/25/2009 | CN101371862A Pharmaceutical combination for preventing birth-defect and improving memory |
02/25/2009 | CN101371860A Pharmaceutical combination for preventing birth-defect and improving memory |
02/25/2009 | CN101371859A Pharmaceutical combination for preventing birth-defect and improving memory |
02/25/2009 | CN101371837A Uses of B vitamins nicotinic amide in regulating body weight, blood sugar and insulin sensibility |
02/25/2009 | CN101371713A Pharmaceutical combination for preventing birth-defect and improving memory |
02/25/2009 | CN101371712A Pharmaceutical combination for preventing birth-defect and improving memory |
02/25/2009 | CN101371711A Pharmaceutical combination for preventing birth-defect and improving memory |
02/25/2009 | CN101371695A Edible health seasoning for diabetic |
02/25/2009 | CN100463955C Extraction method of effective ingredients from ants |
02/25/2009 | CN100463918C Novel epidermal growth factor protein and gene, and methods of use therefor |
02/25/2009 | CN100463611C Processing method of natural bamboo juice soy sauce |
02/24/2009 | US7495109 Nociceptin analogs |
02/24/2009 | US7495020 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
02/24/2009 | US7495009 Imidazopyridine derivatives as melancortin receptor agonists |
02/24/2009 | US7495005 Antidiabetic agents; antiarthritic agents; obesity; graft verses host disease; osteoporosis |
02/24/2009 | US7495004 Purine derivatives as liver X receptor agonists |
02/24/2009 | US7495003 e.g. 1-(naphthyl-1-ylmethyl)-3-(methoxycarbonylmethyl)-7-(but-2-ynyl)-8-(3-amino-piperidin-1-yl)-xanthine; dipeptidyl-peptidase-IV (DPP-IV) inhibitor; antidiabetic, diuretic, antihypertensive agent; insulin resistance, obesity; irritable bowel syndrome (IBS), Crohn's disease, ulcerative colitis |
02/24/2009 | US7495002 e.g. 1-[(3-methyl-isoquinolin- 1 -yl)methyl]-3-methyl-7-(2-butyn- 1 -yl)-8-[(2-amino-ethyl) -methylamino]-xanthine; dipeptidyl-peptidase-IV (DPP-IV) inhibitor; antidiabetic, diuretic, antihypertensive agent; insulin resistance, obesity; irritable bowel syndrome (IBS), Crohn's disease, ulcerative colitis |
02/24/2009 | US7494978 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
02/24/2009 | US7494824 Interactive system for presenting and eliminating substances |
02/24/2009 | US7494680 Fat or oil composition |
02/24/2009 | US7494661 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
02/24/2009 | CA2469813C Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
02/24/2009 | CA2443543C Supplementation of equine feedstuffs |
02/24/2009 | CA2432085C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
02/24/2009 | CA2339913C Pharmaceutical formulations and method for making |